Andrew Smith
Foot & Ankle Surgery · Augusta, MENPI 1649276411
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 8 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $131, 3.1 times the $42 reported in 2019. That places this record below the midpoint for foot & ankle surgery clinicians in ME, where the typical reported total is $723.
Across 17 payments — averaging $19.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$65
- Urgo Medical North America, LLC$56
- Smith+Nephew$49
- Mimedx Group, Inc.$42
- Astellas Pharma US Inc$40
- Pacira Pharmaceuticals Incorporated$38
- plus $48 from 2 others
What the payments were for
- Food & beverage$338100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 6 | $65 |
| Urgo Medical North America, LLC | 2 | $56 |
| Smith+Nephew | 2 | $49 |
| Mimedx Group, Inc. | 2 | $42 |
| Astellas Pharma US Inc | 2 | $40 |
| Pacira Pharmaceuticals Incorporated | 1 | $38 |
| Getinge USA Sales, LLC | 1 | $28 |
| Metric Medical Devices, Inc. | 1 | $21 |
How this compares
$338 in reported general payments places this provider in the 35th percentile of 33 foot & ankle surgery providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $6,861 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 59 | $499 |
| Clindamycin Hcl | 36 | $386 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 65 | $377 |
| Oxycodone Hcl | 23 | $118 |
| Lisinopril | 11 | $96 |
| Levofloxacin | 17 | $71 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Augusta
- Michael KippAugusta$260
- Henry ScheullerAugusta$138
- Barry WhiteYarmouth$330K
- Ashley MychakRockport$84K
- Jules BodoPortland$18K
- James FullwoodPittsfield$17K
- Todd ObrienOld Town$4K
- Kenneth FlaniganPortland$3K
- Thanh Thao NguyenScarborough$3K
- Rihua ChenBiddeford$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.